The activity of Sac1 across ER–TGN contact sites requires the four-phosphate-adaptor-protein-1

por Venditti, Rossella, Masone, Maria Chiara, Rega, Laura Rita, Di Tullio, Giuseppe, Santoro, Michele, Polishchuk, Elena, Serrano, Ivan Castello, Olkkonen, Vesa M., Harada, Akihiro, Medina, Diego L., La Montagna, Raffaele, De Matteis, Maria Antonietta
Publicado 2019

Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin

por Mariniello, Marta, Petruzzelli, Raffaella, Wanderlingh, Luca G., La Montagna, Raffaele, Carissimo, Annamaria, Pane, Francesca, Amoresano, Angela, Ilyechova, Ekaterina Y., Galagudza, Michael M., Catalano, Federico, Crispino, Roberta, Puchkova, Ludmila V., Medina, Diego L., Polishchuk, Roman S.
Publicado 2020